Formation and activity of NLRP3 inflammasome and histopathological changes in the lung of corpses with COVID-19
M Gholaminejhad, M Forouzesh, B Ebrahimi… - Journal of Molecular …, 2022 - Springer
COVID-19 is a contagious disease that attacks many organs but the lungs are the main
organs affected. The inflammasome activation results in the exacerbation of inflammatory …
organs affected. The inflammasome activation results in the exacerbation of inflammatory …
Bradykinin-target therapies in SARS-CoV-2 infection: current evidence and perspectives
MF da Silva, JX de Araujo-Junior… - Naunyn-schmiedeberg's …, 2022 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is a potentially fatal disease caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that preferentially infects …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that preferentially infects …
The role of ACE2 in the renin-angiotensin-system: Etiology and therapy of COVID-19 from a pharmaceutical perspective
CR Noe, M Noe-Letschnig - Die Pharmazie-An International …, 2021 - ingentaconnect.com
Angiotensin-2 converting enzyme (ACE2), a key element of the renin-angiotensin-system
(RAS), is not only the direct target of infection by the human SARS-Cov-2 virus but is at the …
(RAS), is not only the direct target of infection by the human SARS-Cov-2 virus but is at the …
Vitamin D and COVID-19: A physiological perspective
P Sindhusen - Biomedical Research and Therapy, 2021 - bmrat.biomedpress.org
Known for its ability to enhance the performance of the immune system, preclude microbial
infections, and reduce susceptibility to influenza, Vitamin D (or 1, 25-dihydroxyvitamin D (1 …
infections, and reduce susceptibility to influenza, Vitamin D (or 1, 25-dihydroxyvitamin D (1 …
[PDF][PDF] Stem cells: a promising therapeutic target for COVID-19
TH Leyla, X Nan - Stem Cell Discovery, 2022 - escholarship.org
A large variety of therapeutic products have been developed as vaccines or treatments of
COVID-19 infection. Meanwhile SARS-CoV-2 continues to mutate and spread. The severe …
COVID-19 infection. Meanwhile SARS-CoV-2 continues to mutate and spread. The severe …
The impact of atherosclerotic cardiovascular disease, dyslipidaemia and lipid lowering therapy on Coronavirus disease 2019 outcomes: An examination of the …
The impact of atherosclerotic cardiovascular disease, dyslip... : Current Opinion in
Lipidology The impact of atherosclerotic cardiovascular disease, dyslipidaemia and lipid …
Lipidology The impact of atherosclerotic cardiovascular disease, dyslipidaemia and lipid …
Lymphocytes count, acute phase protein and renal function in COVID-19 patients as disease severity predictors
IA Abid, II Latif, NF Ghaab - AIP Conference Proceedings, 2023 - pubs.aip.org
Coronavirus disease 2019 is an infection caused by severe acute respiratory syndrome
coronavirus-2. The clinical spectrum of this illness ranges from asymptomatic infection to …
coronavirus-2. The clinical spectrum of this illness ranges from asymptomatic infection to …
Predicting COVID-19 Patients Outcome Trajectories Using Proteomics and Clinical Biosignatures: A Comprehensive Machine Learning and Bioinformatics Approach
E Pona, N Elango, B Zheng, A Dumon… - Available at SSRN …, 2022 - papers.ssrn.com
Despite advances in vaccination and diagnostic tests, the Covid-19 transmission rate and
mortality remain relatively high. Several proteomic studies on COVID-19 prognosis have …
mortality remain relatively high. Several proteomic studies on COVID-19 prognosis have …
[PDF][PDF] Innate immune phenotype variation in bovine health and disease
CM Reid - 2023 - tara.tcd.ie
Infectious diseases are estimated to cost the global agriculture industry $300 billion annually
and present significant challenges to animal welfare. Disease burden in cattle and other …
and present significant challenges to animal welfare. Disease burden in cattle and other …